Novartis Settles U.S. Bribery Charges
The pharma giant will pay more than $346 million to settle charges that it bribed doctors to prescribe their drugs.
Novartis to Buy AveXis in $8B Gene Therapy Bet
The deal gives the Swiss drugmaker a neurological disease treatment that may have "a multi-billion dollar peak sales potential."
GSK Buys Novartis out of Joint Venture for $13B
The acquisition of Novartis' stake will give GSK full control over the revenues from such products as Sensodyne toothpaste and the Excedrin pain reliever.
Specialty Drug Costs to Soar Again in 2018
The rate of spending increase on high-tech pharmaceuticals will top 17% for a second consecutive year, a study says.
Novartis Settles Kickback Charges for $370M
The Swiss drug maker allegedly turned specialty pharmacies into a "biased sales force" for its medications.
CFO Snapshot: Sweating in Front of the Board
Meryl Zausner, the U.S. finance chief of Novartis, shares her thoughts on the CFO role and the path she took to get there.